|
1 Xie XK, Tang SM, Lv XL, et al. A study of opioid peptide in the CSF of epilepsy patients. Chin J Neuro Pshychia，1991，24：15–17.
|
|
2 Chen L, Zou ZY, Lin LF, et al. Expression of Leu–enkephalin in different cerebral regions of rats with pentylenetetrazol–induced epilepsy and its significance. Chin J Neuromed, 2005，4(8)：783–789.[陈琅，邹漳钰，林立芳，等．实验性癫痫大鼠不同脑区L–ENK的表达及意义．中华神经医学杂志，2005，4(8)：783–789.]
|
|
3 Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature, 1982，296：659–660.
|
|
4 Erickson JC, Clegg KE, Palmiter RD. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature, 1996，381(6581)：415–418.
|
|
5 Reibel S, Larmet Y, Carnahan J, et al. Endogenous control of hippocampal epileptogenesis a molecular cascade involving brain–derived neurotrophic factor and neuropeptide Y. Epilepsia, 2000，41：s127–133.
|
|
6 Vezzani A, Ravizza T, Moneta D, et al. Brain–derived neurotrophic factor immunoreactivity in the limbic system of rats after acute seizures and during spontaneous convulsions: Temporal evolution of changes as compared to neuropeptide Y. Neuroscience, 1999，90(4): 1445–1461.
|
|
7 Woldbye DP, Larsen PJ, Mikkelsen JD, et al. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5–like receptors. Nat Med，1997，3(7)：761–764.
|
|
8 DePrato PS, Holmes P, Martin R, et al. Experimentally induced attenuation of neuropeptide–Y gent expression in transgenic mice increase mortality rate following seizures. Neurosci Lett，2000，287：61–64.
|
|
9 Chen L, Ji XL, Zou ZY, et al. A study of the significance of various expression of Neuropeptide Y in brain of pentylenetrazol–induced rats. Chin J Neuroimmunol Neurol, 2005，12(2)：118–121.[陈琅，季晓林，邹漳钰，等．戊四氮致痫大鼠不同脑区神经肽Y的表达及意义．中国神经免疫学和神经病学杂志，2005，12(2)：118–121.]
|
|
10 Racine RJ. Modification of seizure activity by electrical stimulation.Ⅱ.Motor seizure. Electroencephalogr Clin Neurophysil，1972，32：281.
|
|
11 Klioueva IA, van Luijtelaar E，Chepurnova NE, et al. PTZ–induced seizures in rats: Effects of age and strain. Physiol Behav, 2001，72：421–426.
|
|
12 Corda MG, Orlandi M, Lecca D, et al. Pentylenetrazol–induced kindling in rats: Effect of GABA function inhibitors. Pharmacol Biochem Behav, 1991，40：329–333.
|
|
13 Rocha L, Cano A, Cruz C, et al. Opioid peptide systems following a subconvulsant dose of pentylenetetrazol in rats. Epilepsy Res，1999，37：141–150.
|
|
14 Vezzani A, Sperk G, Colmers WF. Neuropeptide Y: Emerging evidence for a functional role in seizure modulation. Trends Neurosci，1999，22：25–30.
|
|
15 Vezzani A, Michalkiewicz M, Moneta D, et al. Seizure susceptibility and epileptogenesis are decreased in transgenic rats overexpressing neuropeptide Y. Neurosci，2002，110：237–243.
|
|
16 Chen L, Ji XL. Enkephalin, neuropeptide Y, neuron–specific enolase and epilepsy. Foreign Med Infor, 2004，25(1)：7–11.[陈琅，季晓林．脑啡肽、神经肽Y、神经元特异性烯醇酶与癫痫．国外医学情报，2004，25(1)：7–11.]
|
|
17 Wu YF, Li SB.Neuropeptide Y expression in mouse hippocampus and its role in neuronal excitotoxicity. Acta Pharmacol Sinaca, 2005，26(1)：63–68.
|
|
18 Vezzani A, Civenni G, Rizzi M, et al. Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats. Brain Res, 1994，660(1)：138–142.
|
|
19 Fu LY, Claudio AG, Anthony NP. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: Tonic depression of the hypothalamic arousal system.J Neurosci, 2004, 24(40)：8741–8751.
|
|
20 Baraban SC, Hollopeter G, Erickson JC, et al. Knock–out mice reveal a critical antiepileptic role for neuropeptide Y. J Neurosci, 1997，17(23)：8927.
|
|
21 Woldbye DPD. Antiepilepsytic effects of NPY on pentylenetetrazole seizures. Regulat Peptid，1998，75–76：279–282.
|
|
22 Duan RS, Jin S, Chi ZF. Effects of lateral ventricle infusion with neuropeptide–Y on expression of brain–derived neurotrophic factor in hippocampus after pentylenetetrazol–induced epileptic seizure in rats. J Brain Nerv Dise, 2002，10(5)：275–278.[段瑞生，金善，迟兆富．脑室内灌注神经肽Y对戊四氮致痫大鼠海马结构内脑源性神经营养因子表达的影响．脑与神经疾病杂志，2002，10(5)：275–278.]
|
|
23 Patrylo PR, van Den Pol A, Spencer DD, et al. NPY inhibits glutamaterigic exicitation in the epileptic human dentate gyrus. J Neurophysiol, 1999，82(1)：478–483.
|
|
24 Urca G, Frenk M. Intracerebral opiates blocks the epileptic effect of intracerebroventricular leucine–enkephalin. Brain Res, 1983，259：103–106.
|
|
25 Ishikura N, Tsunashima K, Watanabe K, et al. Temporal change of hippocampal enkephalin and dynorphin mRNA following trimethyltin intoxication in rats: Effect of anticonvulsant. Neurosci Lett，2001，306：157–160.
|
|
26 Rocha L, Maidment NT. Opioid peptide relaease in the rat hippocampus after kainic acid–induced status epilepticus. Hippocampus，2003，13：472–480.
|
|
27 Fetissov SO, Jacoby AS, Brumovsky PR, et al. Alter hippocampal expression of neuropeptides in seizure–prone GALR1 knockout mice. Epilepsia, 2003，44：1022–1033.
|
|
28 Harrison MB, Shumate MD, Lothman EN. Opioid peptide expression in models of chronic temporal lobe epilepsy. Neurosci, 1995，65：785–795.
|
|
29 Chen L, Zou ZY, Chen X, et al. The study of neuron damage of rat hippocampus after PTZ–induced seizure. J Brain Nerv Dise, 2005，13(3)：200–203.[陈琅，邹漳钰，陈新，等．PTZ致痫大鼠海马区神经元损伤的研究．脑与神经疾病杂志，2005，13(3)：200–203.]
|
|
30 Chen L, Zhao XZ, Zou ZY, et al. Changes of ultrastructure of rat hippocampus CA1 after PTZ–induced seizure. J Fujian Med Univ, 2004，38(4)：448–450.[ 陈琅，赵晓贞，邹漳钰，等．戊四氮致痫大鼠海马CA1区超微结构改变．福建医科大学学报，2004，38(4)：448–450.]
|